Neuroendocrinal, Neurodevelopmental, and Embryotoxic Effects of Recombinant Tissue Plasminogen Activator Treatment for Pregnant Women with Acute Ischemic Stroke

Thrombolysis with recombinant tissue plasminogen activator (rTPA) was the first evidence-based treatment approved for acute stroke. Ischemic stroke is relatively uncommon in fertile women but treatment is often delayed or not given. In randomized trials, pregnancy has been an exclusion criterion for...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinberg, Anna, Moreira, Tiago P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766278/
https://www.ncbi.nlm.nih.gov/pubmed/26941596
http://dx.doi.org/10.3389/fnins.2016.00051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766278/
https://www.ncbi.nlm.nih.gov/pubmed/26941596
http://dx.doi.org/10.3389/fnins.2016.00051

Ejemplares similares